Objective: This study sought to examine the effectiveness of sibutramine, a weight loss
agent, on clozapine‐associated weight gain. Method: This was a 12‐week double‐blind …

Weight gain represents a frequent side effect of antipsychotic drug treatment. The current
trial investigated the effect of add-on treatment with sibutramine in schizophrenia outpatients …

OBJECTIVE: Weight gain is commonly observed with olanzapine treatment and can
increase the risk for obesity, cardiovascular disease, hypertension, and diabetes mellitus …

Objective The aim of this study was to determine the prevalence and clinical relevance of
weight gain during clozapine treatment. Previous reports indicated clinically significant …

Background: Weight gain is a common side effect of clozapine treatment and may expose
patients to obesity-associated health risks. We proposed that concomitant treatment with an …

Objective: The aim of this study was to test whether the initial antipsychotic response to
clozapine is related to subsequent weight change. Method: This study was an 8-year …

Objective This study examined whether clozapine induces more weight gain than
haloperidol and whether weight gain is related to clinical improvement. Method The weight …

Background To investigate the association of clozapine treatment and weight gain, we
studied short-and long-term weight gain, correlation of weight gain with treatment response …

Background: Some, but not all, previous studies have indicated that weight gain is
associated with greater improvement in psychopathology during clozapine treatment …

Background Long-term use of clozapine for individuals with schizophrenia carries a high risk
for developing metabolic abnormalities, especially clozapine-induced weight gain. Previous …